AstraZeneca PLC (LON:AZN)
London · Delayed Price · Currency is GBP · Price in GBX 13,632
-108 (-0.79%)
May 15, 2026, 5:09 PM GMT
AstraZeneca Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 10,389 | 10,225 | 7,035 | 5,955 | 3,288 | 112 |
Depreciation & Amortization | 5,474 | 5,392 | 4,981 | 4,851 | 5,178 | 4,039 |
Other Amortization | 236 | 236 | 200 | 280 | 292 | 311 |
Loss (Gain) From Sale of Assets | -123 | -155 | -60 | -292 | -216 | -509 |
Asset Writedown & Restructuring Costs | 243 | 243 | 1,623 | 456 | 226 | 2,428 |
Loss (Gain) From Sale of Investments | - | - | - | - | - | -776 |
Loss (Gain) on Equity Investments | 12 | 7 | 28 | 12 | 5 | 64 |
Stock-Based Compensation | 366 | 366 | 42 | -71 | 27 | 45 |
Other Operating Activities | -665 | -602 | -1,095 | -1,146 | -2,749 | -1,772 |
Change in Accounts Receivable | -1,728 | -1,728 | -1,624 | -1,425 | -1,349 | -961 |
Change in Inventory | -755 | -755 | -131 | -669 | 3,941 | 1,577 |
Change in Accounts Payable | 1,346 | 1,346 | 862 | 2,394 | 1,165 | 1,405 |
Operating Cash Flow | 14,221 | 14,575 | 11,861 | 10,345 | 9,808 | 5,963 |
Operating Cash Flow Growth | 8.66% | 22.88% | 14.65% | 5.47% | 64.48% | 24.25% |
Capital Expenditures | -2,928 | -2,810 | -1,924 | -1,361 | -1,091 | -1,091 |
Sale of Property, Plant & Equipment | 20 | 13 | 55 | 132 | 282 | 13 |
Cash Acquisitions | -1,125 | -1,230 | -3,782 | -1,099 | -1,035 | -10,117 |
Sale (Purchase) of Intangibles | -3,374 | -2,959 | -2,539 | -2,126 | -1,033 | -522 |
Investment in Securities | -226 | -108 | -133 | -87 | -143 | 605 |
Other Investing Activities | 286 | 286 | 343 | 477 | 60 | 54 |
Investing Cash Flow | -7,347 | -6,808 | -7,980 | -4,064 | -2,960 | -11,058 |
Short-Term Debt Issued | - | 364 | - | 161 | 74 | - |
Long-Term Debt Issued | - | 15 | 6,492 | 3,816 | - | 12,929 |
Total Debt Issued | 3,604 | 379 | 6,492 | 3,977 | 74 | 12,929 |
Short-Term Debt Repaid | - | - | -31 | - | - | -276 |
Long-Term Debt Repaid | - | -2,401 | -4,968 | -5,210 | -1,515 | -4,999 |
Total Debt Repaid | -2,412 | -2,401 | -4,999 | -5,210 | -1,515 | -5,275 |
Net Debt Issued (Repaid) | 1,192 | -2,022 | 1,493 | -1,233 | -1,441 | 7,654 |
Issuance of Common Stock | 42 | 40 | 38 | 33 | 29 | 29 |
Repurchase of Common Stock | -647 | -521 | -81 | - | - | - |
Common Dividends Paid | -4,786 | -4,846 | -4,606 | -4,491 | -4,364 | -3,856 |
Other Financing Activities | -371 | -195 | -840 | -876 | -1,047 | -178 |
Financing Cash Flow | -4,570 | -7,544 | -3,996 | -6,567 | -6,823 | 3,649 |
Foreign Exchange Rate Adjustments | 3 | 46 | -93 | -60 | -80 | -62 |
Net Cash Flow | 2,307 | 269 | -208 | -346 | -55 | -1,508 |
Free Cash Flow | 11,293 | 11,765 | 9,937 | 8,984 | 8,717 | 4,872 |
Free Cash Flow Growth | 1.26% | 18.40% | 10.61% | 3.06% | 78.92% | 26.94% |
Free Cash Flow Margin | 18.68% | 20.03% | 18.38% | 19.61% | 19.66% | 13.02% |
Free Cash Flow Per Share | 7.23 | 7.53 | 6.36 | 5.75 | 5.59 | 3.41 |
Cash Interest Paid | 1,335 | 1,316 | 1,313 | 1,081 | 849 | 721 |
Cash Income Tax Paid | 3,008 | 2,845 | 2,750 | 2,366 | 1,623 | 1,743 |
Levered Free Cash Flow | 6,539 | 7,865 | 8,461 | 9,040 | 12,485 | -1,845 |
Unlevered Free Cash Flow | 7,282 | 8,581 | 9,222 | 9,602 | 12,843 | -1,608 |
Change in Working Capital | -1,711 | -1,137 | -893 | 300 | 3,757 | 2,021 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.